BiotechTube
Home/PolTREG/Prof. Małgorzata Myśliwiec
PM

Prof. Małgorzata Myśliwiec

Founder, Key Shareholder

PolTREG

Therapeutic Areas

Type 1 DiabetesMultiple SclerosisAutoimmune Diseases

PolTREG Pipeline

DrugIndicationPhase
PTG007Type 1 DiabetesPhase 1/2
CAR-Treg ProgramMultiple SclerosisPre-clinical

Leadership Team at PolTREG

PP
Prof. Piotr Trzonkowski
Founder, Key Shareholder
PN
Prof. Natalia Marek-Trzonkowska
Founder, Key Shareholder
View full PolTREG profile